Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz


1. Indicine-n-oxide
2. Nsc 132319
1. 41708-76-3
2. Indicine-n-oxide
3. [(7r,8r)-7-hydroxy-4-oxido-5,6,7,8-tetrahydro-3h-pyrrolizin-4-ium-1-yl]methyl (2r)-2-hydroxy-2-[(1s)-1-hydroxyethyl]-3-methylbutanoate
4. Nsc132319
5. Nsc-132319
6. Nsc 132319
7. (+)-indicine N-oxide
8. Indicin-n-oxid
9. Indicine, N-oxide
10. Indicine N-oxide, Hplc Grade
11. Chembl512655
12. Dtxsid101315334
13. Bdbm50480295
14. Mfcd00866484
15. Nci60_000712
16. Hy-105529
17. Cs-0026202
18. [(7r,8r)-7-hydroxy-4-oxido-5,6,7,8-tetrahydro-3h-pyrrolizin-4-ium-1-yl]methyl (2r)-2-hydroxy-2-[(1s)-1-hydroxyethyl]-3-methyl-butanoate
19. Butanoic Acid, (2r,3s)-dihydroxy-2-(1-methylethyl)-(2,3,5,7a-tetrahydro-(1r)-hydroxy-1h-pyrrolizin-7-yl)methyl Ester, N-oxide
20. Butanoic Acid,3-dihydroxy-2-(1-methylethyl)- (2,3,5,7a-tetrahydro-1-hydroxy-1h-pyrrolizin-7-yl) Methyl Ester, N-oxide, (1r-(1.alpha.,7(2r*,3s*),7a.beta))-
| Molecular Weight | 315.36 g/mol |
|---|---|
| Molecular Formula | C15H25NO6 |
| XLogP3 | -1 |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 6 |
| Rotatable Bond Count | 6 |
| Exact Mass | 315.16818752 g/mol |
| Monoisotopic Mass | 315.16818752 g/mol |
| Topological Polar Surface Area | 105 Ų |
| Heavy Atom Count | 22 |
| Formal Charge | 0 |
| Complexity | 479 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 4 |
| Undefined Atom Stereocenter Count | 1 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Antineoplastic Agents, Phytogenic
Agents obtained from higher plants that have demonstrable cytostatic or antineoplastic activity. (See all compounds classified as Antineoplastic Agents, Phytogenic.)
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
95
PharmaCompass offers a list of Indicine-N-Oxide API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Indicine-N-Oxide manufacturer or Indicine-N-Oxide supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Indicine-N-Oxide manufacturer or Indicine-N-Oxide supplier.
PharmaCompass also assists you with knowing the Indicine-N-Oxide API Price utilized in the formulation of products. Indicine-N-Oxide API Price is not always fixed or binding as the Indicine-N-Oxide Price is obtained through a variety of data sources. The Indicine-N-Oxide Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Indicine-N-Oxide manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Indicine-N-Oxide, including repackagers and relabelers. The FDA regulates Indicine-N-Oxide manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Indicine-N-Oxide API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Indicine-N-Oxide supplier is an individual or a company that provides Indicine-N-Oxide active pharmaceutical ingredient (API) or Indicine-N-Oxide finished formulations upon request. The Indicine-N-Oxide suppliers may include Indicine-N-Oxide API manufacturers, exporters, distributors and traders.
click here to find a list of Indicine-N-Oxide suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Indicine-N-Oxide DMF (Drug Master File) is a document detailing the whole manufacturing process of Indicine-N-Oxide active pharmaceutical ingredient (API) in detail. Different forms of Indicine-N-Oxide DMFs exist exist since differing nations have different regulations, such as Indicine-N-Oxide USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Indicine-N-Oxide DMF submitted to regulatory agencies in the US is known as a USDMF. Indicine-N-Oxide USDMF includes data on Indicine-N-Oxide's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Indicine-N-Oxide USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Indicine-N-Oxide suppliers with USDMF on PharmaCompass.
Indicine-N-Oxide Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Indicine-N-Oxide GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Indicine-N-Oxide GMP manufacturer or Indicine-N-Oxide GMP API supplier for your needs.
A Indicine-N-Oxide CoA (Certificate of Analysis) is a formal document that attests to Indicine-N-Oxide's compliance with Indicine-N-Oxide specifications and serves as a tool for batch-level quality control.
Indicine-N-Oxide CoA mostly includes findings from lab analyses of a specific batch. For each Indicine-N-Oxide CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Indicine-N-Oxide may be tested according to a variety of international standards, such as European Pharmacopoeia (Indicine-N-Oxide EP), Indicine-N-Oxide JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Indicine-N-Oxide USP).